Polaris Inc (NYSE:PII) reported a second-quarter FY22 sales growth of 8% year-on-year to $2.06 billion, missing the consensus of $2.18 billion. Retail…
Alzamend Neuro Inc (NASDAQ: ALZN) received a "Study May Proceed" letter from the FDA for the initiation of study AL001-PTSD01, a Phase 2A study of AL001 for